ArticleMethodsX2025
Development of an explainable machine learning model for Alzheimer's disease prediction using clinical and behavioural features.
Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Artificial Intelligence-based detection of neuropsychiatric lupus: an exploratory meta-analysis of neuroimaging and multimodal biomarker models.Clinical and experimental medicine · 2026Pooled it
- Explainable Machine Learning for Predicting Dengue Recovery Duration: Insights from Multi-Center Clinical Data.Healthcare (Basel, Switzerland) · 2026Article
- Explainable Patient-Level Cognitive Impairment Screening via Temporal, Semantic, and Psycholinguistic Multimodal AI.Journal of Intelligence · 2026Article
- FUSION-AD: interpretable AI framework for risk assessment and subgroup discovery in Alzheimer's disease.Frontiers in neuroinformatics · 2026Article
- Developing SHAP interpretable machine learning models for assessing biopsychosocial risk in female drug users: a small sample study.Frontiers in psychiatry · 2026Article
- Liver stiffness measurement-based risk score for predicting liver decompensation risk: a single-center retrospective Chinese study.Clinical and experimental medicine · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article presents a reproducible machine learning methodology for the early prediction of Alzheimer's disease (AD) using clinical and behavioural data. A comparative analysis of multiple classification algorithms was conducted, with the Gradient Boosting classifier yielding the best performance (accuracy: 93.9 %, F1-score: 91.8 %). To improve interpretability, SHapley Additive exPlanations (SHAP) were integrated into the workflow to quantify feature contributions at both global and individual levels. Key predictive variables such as Mini-Mental State Examination (MMSE), Activities of Daily Living (ADL), cholesterol levels, and functional assessment scores were identified and visualized using SHAP-based insights. A user-friendly, interactive web application was developed using Streamlit, allowing real-time patient data input and transparent model output visualization. This method offers a practical tool for clinicians and researchers to support early diagnosis and personalized risk assessment of AD, thus aiding in timely and informed clinical decision-making. Accurate Prediction: Gradient Boosting model achieved 93.9 % accuracy for early Alzheimer's detection. Explainability: SHAP values provided interpretable insights into key clinical features. Clinical Tool: A Streamlit-based web app enabled real-time, explainable predictions for users.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.